The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.1M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 698K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

20 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Fatty Acid Amide Hydrolase (FAAH), Acetylcholinesterase (AChE), and Butyrylcholinesterase (BuChE): Networked Targets for the Development of Carbamates as Potential Anti-Alzheimer's Disease Agents.EBI
Alma Mater Studiorum-University of Bologna
Combined inhibition of the EGFR/AKT pathways by a novel conjugate of quinazoline with isothiocyanate.EBI
Alma Mater Studiorum-University of Bologna
Versatility of the Curcumin Scaffold: Discovery of Potent and Balanced Dual BACE-1 and GSK-3ß Inhibitors.EBI
Alma Mater Studiorum-University of Bologna
2-Phenoxy-1,4-naphthoquinones: From a Multitarget Antitrypanosomal to a Potential Antitumor Profile.EBI
Alma Mater Studiorum-University of Bologna
Multitarget drug design strategy: quinone-tacrine hybrids designed to block amyloid-ß aggregation and to exert anticholinesterase and antioxidant effects.EBI
Alma Mater Studiorum-University of Bologna
Design, synthesis, and biological evaluation of pirenzepine analogs bearing a 1,2-cyclohexanediamine and perhydroquinoxaline units in exchange for the piperazine ring as antimuscarinics.EBI
Alma Mater Studiorum-University of Bologna
Single-digit nanomolar inhibitors lock the aromatase active site via a dualsteric targeting strategy.EBI
Alma Mater Studiorum-University of Bologna
Balanced dual acting compounds targeting aromatase and estrogen receptor α as an emerging therapeutic opportunity to counteract estrogen responsive breast cancer.EBI
Alma Mater Studiorum-University of Bologna
Targeting Orthosteric and Allosteric Pockets of Aromatase via Dual-Mode Novel Azole Inhibitors.EBI
Alma Mater Studiorum-University of Bologna
Discovery of the First-in-Class GSK-3β/HDAC Dual Inhibitor as Disease-Modifying Agent To Combat Alzheimer's Disease.EBI
Alma Mater Studiorum-University of Bologna
Polycyclic maleimide-based derivatives as first dual modulators of neuronal calcium channels and GSK-3β for Alzheimer's disease treatment.EBI
Alma Mater Studiorum-University of Bologna
Discovery of novel benzofuran-based compounds with neuroprotective and immunomodulatory properties for Alzheimer's disease treatment.EBI
Alma Mater Studiorum-University of Bologna
Naphthalene diimide-polyamine hybrids as antiproliferative agents: Focus on the architecture of the polyamine chains.EBI
Alma Mater Studiorum-University of Bologna
Novel polyamine-based Histone deacetylases-Lysine demethylase 1 dual binding inhibitors.EBI
Alma Mater Studiorum-University of Bologna
Drifting of heme-coordinating group in imidazolylmethylxanthones leading to improved selective inhibition of CYP11B1.EBI
Alma Mater Studiorum-University of Bologna
Tau-Centric Multitarget Approach for Alzheimer's Disease: Development of First-in-Class Dual Glycogen Synthase Kinase 3β and Tau-Aggregation Inhibitors.EBI
Alma Mater Studiorum-University of Bologna
Novel Polyamine-Naphthalene Diimide Conjugates Targeting Histone Deacetylases and DNA for Cancer Phenotype Reprogramming.EBI
Alma Mater Studiorum-University of Bologna
Quinazoline based αEBI
Alma Mater Studiorum-University of Bologna
Hydroxy-substituted trans-cinnamoyl derivatives as multifunctional tools in the context of Alzheimer's disease.EBI
Alma Mater Studiorum-University of Bologna
Novel xanthone-polyamine conjugates as catalytic inhibitors of human topoisomerase IIα.EBI
Alma Mater Studiorum-University of Bologna